Protalix BioTherapeutics (PLX) EBITDA Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 10,142.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,142.00 |
| Dec 31, 2025 | -4,085.00 |
| Sep 30, 2025 | -1,003.00 |
| Jun 30, 2025 | 2,543.00 |
| Mar 31, 2025 | 9,200.00 |
| Dec 31, 2024 | 9,495.00 |
| Sep 30, 2024 | 4,230.00 |
| Jun 30, 2024 | -7,387.00 |
| Mar 31, 2024 | -10,392.00 |
| Dec 31, 2023 | -14,054.00 |
| Sep 30, 2023 | 379.00 |
| Jun 30, 2023 | 12,133.00 |
| Mar 31, 2023 | -1,402.00 |
| Dec 31, 2022 | 15,374.00 |
| Sep 30, 2022 | -640.00 |
| Jun 30, 2022 | 7,951.00 |
| Mar 31, 2022 | 2,110.00 |
| Dec 31, 2021 | -8,131.00 |
| Sep 30, 2021 | 829.00 |
| Jun 30, 2021 | -12,219.00 |
| Mar 31, 2021 | -5,441.00 |
| Dec 31, 2020 | -118.00 |
| Sep 30, 2020 | -1,309.00 |
| Jun 30, 2020 | 2,725.00 |
| Mar 31, 2020 | 7,469.00 |
| Dec 31, 2019 | 22,485.00 |
| Sep 30, 2019 | 55,342.00 |
| Jun 30, 2019 | 28,851.00 |
| Mar 31, 2019 | 6,012.00 |
| Dec 31, 2018 | 32,322.00 |
| Sep 30, 2018 | -46,108.00 |
| Jun 30, 2018 | -16,625.00 |
| Mar 31, 2018 | 27,356.00 |
| Dec 31, 2017 | -11,330.00 |
| Sep 30, 2017 | 3,918.00 |
| Jun 30, 2017 | 39,145.00 |
| Mar 31, 2017 | 77,148.00 |
| Sep 30, 2016 | 23,205.00 |
| Jun 30, 2016 | -14,343.00 |
| Mar 31, 2016 | -83,997.00 |
| Mar 31, 2015 | -22,161.00 |
| Mar 31, 2014 | 2,754.00 |
| Dec 31, 2013 | 107,812.00 |
| Sep 30, 2013 | -9,785.00 |
| Jun 30, 2013 | -34,135.00 |
| Mar 31, 2013 | 3,295.00 |
| Dec 31, 2012 | -49,247.00 |
| Sep 30, 2012 | 62,517.00 |
| Jun 30, 2012 | 185,202.00 |
| Mar 31, 2012 | -3,504.00 |
| Dec 31, 2011 | 37,736.00 |
| Sep 30, 2011 | -68,502.00 |
| Jun 30, 2011 | -92,561.00 |